Very disappointing news released today about a Phase 3 drug study for ALS.
Biogen Idec Reports Top-Line Results from
Phase 3 Trial Investigating Dexpramipexole in People with Amyotrophic
Lateral Sclerosis (ALS)
http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1770780
I hope there is success in a medicine which will allow people living with ALS a more comfortable life.
No comments:
Post a Comment